Prostate Clinical Trials

The Prostate Active Surveillance Study (PASS) is a study designed to identify and validate biomarkers that predict aggressive prostate cancer. PASS is funded by Canary Foundation and coordinated by National Cancer Institute’s Early Detection Research Network (EDRN).

→ Meet the Prostate Cancer Research Team
→ Learn more about Prostate Cancer Research Program